FAST Heroes: Results of Cross-Country Implementation of a Global School-Based Stroke Education Campaign.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 05 01 2022
accepted: 11 03 2022
entrez: 5 5 2022
pubmed: 6 5 2022
medline: 7 5 2022
Statut: epublish

Résumé

Educating the at-risk population about stroke symptoms and requirement of calling an ambulance when stroke strikes is challenging. This exploratory cross-country study provides insights to the FAST Heroes educational campaign and outcomes hitherto achieved. The primary aim of the study was to measure the transfer of stroke-related knowledge to parents after a global school-based FAST Heroes educational campaign for 5- to 9-year-old children in 14 different countries. The secondary aim was to evaluate parents and teachers' acceptability toward the program. The duration of the program was 5 h; 1 h per week, joining face-to-face educational sessions with workbooks, cartoons, web-based learning, and other fun activities. Outcomes were measured before implementation (t1), after implementation (t2), and at 6-month follow-up (t3). Program acceptability and stroke knowledge were evaluated by feedback surveys for teachers and parents. Worldwide, 4,202 parents completed the program with their children and answered surveys at t1 and t2. They increased their knowledge of three stroke symptoms from 48 to 83% ( Findings confirm the primary aim of the study that is knowledge about stroke transfer well from children to their families through the FAST Heroes program. Second, parents and teachers globally consider the program feasible and worthwhile. The results will inform further rollout of the campaign.

Sections du résumé

Background
Educating the at-risk population about stroke symptoms and requirement of calling an ambulance when stroke strikes is challenging. This exploratory cross-country study provides insights to the FAST Heroes educational campaign and outcomes hitherto achieved.
Aims
The primary aim of the study was to measure the transfer of stroke-related knowledge to parents after a global school-based FAST Heroes educational campaign for 5- to 9-year-old children in 14 different countries. The secondary aim was to evaluate parents and teachers' acceptability toward the program.
Methods
The duration of the program was 5 h; 1 h per week, joining face-to-face educational sessions with workbooks, cartoons, web-based learning, and other fun activities. Outcomes were measured before implementation (t1), after implementation (t2), and at 6-month follow-up (t3). Program acceptability and stroke knowledge were evaluated by feedback surveys for teachers and parents.
Results
Worldwide, 4,202 parents completed the program with their children and answered surveys at t1 and t2. They increased their knowledge of three stroke symptoms from 48 to 83% (
Conclusions
Findings confirm the primary aim of the study that is knowledge about stroke transfer well from children to their families through the FAST Heroes program. Second, parents and teachers globally consider the program feasible and worthwhile. The results will inform further rollout of the campaign.

Identifiants

pubmed: 35509512
doi: 10.3389/fpubh.2022.849023
pmc: PMC9058110
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

849023

Informations de copyright

Copyright © 2022 Tsakpounidou, van der Merwe, Klinke, Webb, Ouriques Martins and Proios.

Déclaration de conflit d'intérêts

KT, JM, CW, and HP are employed by Boehringer Ingelheim. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Indian J Crit Care Med. 2019 Jun;23(Suppl 2):S140-S146
pubmed: 31485123
Prev Chronic Dis. 2008 Apr;5(2):A49
pubmed: 18341784
Sleep Med. 2016 May;21:93-100
pubmed: 27448478
Patient Relat Outcome Meas. 2015 Feb 25;6:61-73
pubmed: 25750550
N Engl J Med. 1995 Dec 14;333(24):1581-7
pubmed: 7477192
N Engl J Med. 2008 Sep 25;359(13):1317-29
pubmed: 18815396
Healthcare (Basel). 2021 Nov 26;9(12):
pubmed: 34946363
Prehosp Emerg Care. 1998 Jul-Sep;2(3):170-5
pubmed: 9672689
BMJ Open. 2017 Dec 21;7(12):e017632
pubmed: 29273654
Sch Psychol Q. 2015 Sep;30(3):406-420
pubmed: 25485463
J Sch Health. 2007 Oct;77(8):435-63
pubmed: 17908102
J Stroke Cerebrovasc Dis. 2018 Nov;27(11):3187-3199
pubmed: 30093194
Eur J Neurol. 2021 Feb;28(2):717-725
pubmed: 33043544
PLoS One. 2012;7(10):e46124
pubmed: 23056247
Int J Stroke. 2019 Oct;14(7):NP23-NP24
pubmed: 31496441
Int J Stroke. 2010 Jun;5(3):187-208
pubmed: 20536616
J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):1040-5
pubmed: 24094446
Lancet Glob Health. 2021 Mar;9(3):e340-e351
pubmed: 33422189
Stroke. 2008 Oct;39(10):2809-16
pubmed: 18635851
J Stroke Cerebrovasc Dis. 2018 Jul;27(7):1810-1814
pubmed: 29544681
Stroke. 2015 Feb;46(2):572-4
pubmed: 25523059
Int J Stroke. 2018 Oct;13(7):NP19-NP21
pubmed: 30014780
Obes Rev. 2011 Mar;12(3):205-16
pubmed: 20122137
Stroke. 2018 Apr;49(4):972-979
pubmed: 29567762
Brain Behav. 2021 Jan;11(1):e01944
pubmed: 33185985
Prev Chronic Dis. 2016 Jan 21;13:E11
pubmed: 26796519
Stroke. 2018 Jul;49(7):1766-1769
pubmed: 29925649
Front Neurol. 2021 May 26;12:652321
pubmed: 34122301
BMC Emerg Med. 2017 Jun 24;17(1):20
pubmed: 28646851
Stroke. 2005 May;36(5):1035-9
pubmed: 15817898
Eur J Public Health. 2018 Jun 1;28(3):426-433
pubmed: 29790991
Front Public Health. 2021 May 14;9:638516
pubmed: 34055715
Stroke. 2018 Oct;49(10):2559-2561
pubmed: 30355126
Am J Health Promot. 2021 Jan;35(1):57-67
pubmed: 32551829
Health Econ. 2013 Sep;22(9):1004-20
pubmed: 23780620
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):3988-3993
pubmed: 30670661
J Stroke Cerebrovasc Dis. 2017 Feb;26(2):431-437
pubmed: 27838177
Int J Stroke. 2017 Jun;12(4):401-411
pubmed: 27799456
Eur Stroke J. 2018 Jun;3(2):117-125
pubmed: 31008344

Auteurs

Kalliopi Tsakpounidou (K)

Department of Educational and Social Policy, University of Macedonia, Thessaloniki, Greece.

Jan van der Merwe (J)

Boehringer Ingelheim International Gesellschaft mit Beschränkter Haftung (GmbH), Healthcare Affairs and Patient Engagement, Ingelheim am Rhein, Germany.

Marianne Elisabeth Klinke (ME)

Faculty of Nursing, School of Health Sciences, University of Iceland, Reykjavik, Iceland.

Chris Webb (C)

Twelve, Worthing, United Kingdom.

Sheila Cristina Ouriques Martins (SC)

Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Hospital Moinhos de Vento, Neurology, Porto Alegre, Brazil.

Hariklia Proios (H)

Department of Educational and Social Policy, University of Macedonia, Thessaloniki, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH